Sage Journals: Discover world-class research

Abstract

Introduction

Globally, chronic kidney disease (CKD) has emerged as one of the leading causes of mortality and it is one of a small number of noncommunicable diseases that have shown an increase in associated deaths over the past two decades. Chronic kidney disease affects approximately 50% of patients with type 2 diabetic mellitus (DM).

Objective

To determine CKD preventive attitude, practices, and associated factors among type 2 DM (T2DM) patients attending follow-up in a diabetic clinic at Asella Referral and Teaching Hospital.

Methods

Institutional based cross-sectional study was conducted at Asella Referral and Teaching Hospital among T2DM patients from December 23, 2021, to January 23, 2022. Data were entered into EpiData 4.2.00 and analyzed by Statistical Package for the Social Sciences version 23.0.

Result

A total of 216 study participants were included in to this study. The level of good preventive attitude and practice toward CKD among T2DM patients were 61.6% (n = 133, 95% CI: 55.6–68.0) and 54.6% (n = 118, 95% CI: 47.7–60.6), respectively. Age (50–59 years) (adjusted odds ratio [AOR] = 0.351, 95% CI: 0.125–0.988, p = .047), married (AOR = 4.423, 95% CI: 1.366–14.314, p = .013), urban residents (AOR = 0.321, 95% CI: 0.152–0.680, p = .003), and governmental employed (AOR = 0.269, 95% CI: 0.076–0.954, p = .042) were significantly associated with CKD preventive attitude. Formal education (AOR = 1.686, 95% CI: 1.416–5.502, p = .043), an average monthly income of ≥8000 ETB (AOR = 4.048, 95% CI: 1.129–14.520, p = .032), family history of CKD (AOR = 1.417, 95% CI: 1.231–7.136, p = .045) were significantly associated with CKD preventive practice.

Conclusion

The level of good preventive attitude and practice toward CKD among T2DM patients was 61.6% and 54.6%, respectively. Age, marital status, residence, and occupation were significantly associated with good preventive attitude of T2DM patients. Whereas educational status, average monthly income, and duration since diagnosed with T2DM were significantly associated with good CKD preventive practice. Health educational program needs to occur to improve the preventive attitude and practice toward CKD among T2DM patients.

Keywords

knowledge attitude practice associated factors type 2 DM chronic kidney disease

Introduction

Chronic kidney disease (CKD) is a type of kidney disease in which there is kidney disability and gradual loss of kidney function over a period of months to years (Wikipedia, 2023). Chronic kidney disease can be caused by diabetes, hypertension, glomerulonephritis, pyelonephritis, and interstitial nephritis (Kidney Education, 2023). The modifiable risk factors for CKD are uncontrolled high blood pressure, type 1 diabetic mellitus (DM) with onset before age 20, cigarette smoking, and obesity, while the nonmodifiable risk factors are genetics, race, age >65 years and low birth weight (Veeraish, 2021).

At an early stage, CKD does not show any symptoms, but at later stages it starts to show symptoms such as shortness of breath, edema, increased urination especially at night, blood in urine, itching, insomnia, headache, tiredness, muscle crumps, loss of appetite, and erectile dysfunction (Kidney Resource center, 2023; NHS, 2023). Chronic kidney disease can be classified into five stages based on the estimated GFR; Stage 1 is when e-Gfr is ≥90 ml/min, and this indicates as the kidneys are healthy, but some signs can be seen like protein in the urine. Stage 2 is when GFR is 60–89 ml/min, and this indicates mild kidney damage. Stage 3 is when GFR is 30–59 ml/min, which indicates some kidney damage. Stage 4 is when GFR is 15–29 ml/min and this shows as there is moderate to severe kidney damage. Stage 5 is when GFR is less than 15 ml/min. At this stage, the kidney is very close to failure or has completely failed (Stages of Kidney Disease, 2020).

Review of Literature

Type 2 DM (T2DM) is the leading cause of end-stage renal disease (ESRD) in developed countries (Stages of Kidney Disease, 2023). In 2017, the prevalence of CKD was estimated as 9.1% globally (Bikbov et al., 2020). There is a high prevalence of CKD in patients with T2DM (Calvo-Hueros et al., 2021). Chronic kidney disease globally affects about 50% patients living with T2DM (Rajput et al., 2017; Thomas et al., 2016). The prevalence of CKD among T2DM patients was 43.5% in USA (Rahim et al., 2017), 27.5% in UK (Rahim et al., 2017), 47.1% in Australia (Rahim et al., 2017), 24.3% in Spain (Calvo-Hueros et al., 2021), 23% in Palestine (Naser et al., 2021), 32.07% in Saudi Arabia (Naser et al., 2021), 60.78% in Oman (Naser et al., 2021), 33.6% in Yemen (Naser et al., 2021), 35.4% in Thailand (Jitraknatee et al., 2020), and (13.9–63.5%) in Bangladeshi (Mondal et al., 2021d). In Africa, the prevalence of CKD among T2DM patients ranges from 2% to 41%. Whereas it was 94.9% in South Africa (Geletu et al., 2018), 28.5% in Ghana among T2DM and hypertension (Tannor et al., 2019), and 18.2% in Ethiopia among DM patients (Shiferaw et al., 2020).

Type 2 DM is the leading cause of CKD in the United States, with around 40% of patients with T2DM showing evidence of CKD (Ephraim et al., 2018). Type 2 DM became the second-leading cause of CKD and CKD-related death and the third leading cause of CKD-related disability-adjusted life-years in 2019 (Deng et al., 2021). Chronic kidney disease is associated with premature morbidity and mortality and the risk of progressing to ESRD and mortality rates rise with the advancing severity of CKD (CDC, 2022).

A study done in 2017 showed that T2DM patients having CKD were associated with 2.5 million incident cases, 129.56 million patients, and 405.99 thousand deaths. Chronic kidney disease resulted in 1.2 million deaths globally (Bikbov et al., 2020). The burden of CKD is greater among minor ethnic groups due to increased prevalence of comorbidities and reduced access to health care and due to limited services for the diagnosis, management, and monitoring of CKD at the primary health care level especially in low-income countries like Africa there is a high burden of CKD (Luyckx et al., 2021).

A study done in Palestine showed that prevention and early detection of CKD practice were significantly associated among normal body mass index, urban residents, high educational level, less tobacco use, last HbA1c below 7, and higher knowledge, attitude, and Michigan Diabetic Knowledge Test score (Badran et al., 2023). Besides, a study done in Bangladesh showed that CKD attitude was significantly associated with sex, occupation, and income in T2DM (Mondal et al., 2021a).

Thus, the importance of early CKD detection is to prevent CKD progression and associated complications, thus improving patient outcomes and reducing the impact of CKD on health care resources (Levin & Stevens, 2011). Knowing the magnitude of CKD among T2DM patients is important to prevent cardiovascular complications, kidney failure, ESRD, and to advice if diabetic patients develop CKD not to take certain medicines, such as nonsteroidal anti-inflammatory drugs and to modify their diet to prevent kidney disease from progressing (NIH, 2020).

The previous studies done in different settings indicate that the prevalence of CKD among T2DM is increasing at an alarming rate in both developed and developing countries. It causes a great number of mortalities and morbidities worldwide and it may have an economic impact on patients and to nations. However, even if it causes this entire problem, there is limitation of the study that addressed CKD preventive attitude, practice, and associated factors among T2DM attending follow-up clinic in the study area while also globally. Therefore, this study was aimed to assess the CKD preventive attitude, practice, and associated factors among T2DM patients attending follow-up clinic in Asella Referral and Teaching Hospital, Oromia Regional State, Ethiopia.

Methods

Study Area

The study was done at DM clinic in Asella Referral and Teaching Hospital. This Hospital serves as teaching and at the same time it gives health services for the patients. It is a governmental hospital located in Asella, Arsi zone, Oromia regional state, Ethiopia. Asella is located in the Arsi Zone of the Oromia Region, about 175 km from Addis Ababa, the capital city of Ethiopia (Wikipedia, 2024).

Study Period

The study was conducted from December 23, 2021, to January 23, 2022.

Study Design

Institutional-based cross-sectional study was conducted as per the “Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines and methodologies” (von Elm et al., 2007).

Research Questions

▪ What is the level of CKD preventive attitude among T2DM patients attending follow-up clinic in Asella Referral and Teaching Hospital, Oromia Regional State, Ethiopia?

▪ What is the level of CKD preventive practice among T2DM patients attending follow-up clinic in Asella Referral and Teaching Hospital, Oromia Regional State, Ethiopia?

▪ What are the factors associated with CKD preventive attitude among T2DM patients attending follow-up clinic in Asella Referral and Teaching Hospital, Oromia Regional State, Ethiopia?

▪ What are the factors associated with CKD preventive practice among T2DM patients attending follow-up clinic in Asella Referral and Teaching Hospital, Oromia Regional State, Ethiopia?

Population

Source Population

All T2DM patients attended DM follow up clinic at Asella Referral and Teaching Hospital.

Study Population

All randomly selected T2DM patients attended DM follow up clinic at Asella Referral and Teaching Hospital.

Eligibility Criteria

Inclusion Criteria

All T2DM patients age ≥ 18 years old.

Exclusion Criteria

Type 2 DM patients who have already developed CKD were excluded from this study.

Sample Size Determination

A single population proportion formula was used to determine the sample size. During this, we assumed the prevalence of CKD preventive attitude and practice (p = 50%), because there was no study that was done in Ethiopia. Therefore, the sample size was determined by using the following assumptions;

▪ N = total T2DM patients with monthly follow-up = 400

▪ P = Proportion 50%,

▪ d = margin of error 5%

▪ Z @/2 = 1.96 corresponding to 95% CI.

▪ no = initial sample size

▪ nf = final sample size

▪ 10% for nonresponses

n o = \frac{(Z α / 2) 2 * P (1 - P)}{d 2} = \frac{(1.96) 2 * 0.5 (1 - 0.5)}{(0.05) 2} = 384

Since the total T2DM patients with monthly follow-up were 400, which is less than 10,000, the sample size was adjusted by using correction formula:

n f = \frac{n o}{1 + \frac{n o}{N}}

\frac{384}{1 + \frac{384}{400}}

= 196. By adding 10% for nonresponse, the final sample size was 216.

Sampling Techniques and Procedures

The logbook of all T2DM patients who were attending the diabetic follow-up clinic at Asella Referral and Teaching Hospital was checked carefully. Two of T2DM patients who have already developed CKD were excluded from this study. Whereas those T2DM patients who have attended the diabetic follow-up clinic during data collection and fulfilled the inclusion criteria and volunteer to participate were included in to this study.

Then, all T2DM patients who were attending the diabetic follow-up clinic were numbered in sequence from 1 to 398. Next, a simple random sampling technique; Table of random numbers was used to select the study participants until it reach the detrmined sample size (216).

Study Variable

Dependent Variable

Chronic kidney disease preventive attitude

Chronic kidney disease preventive practice

Independent Variable

Sociodemographic variables: Gender, age, educational level, average monthly income, and marital status.

Clinical-related variables: Duration since diagnosed with T2DM, family history of CKD, number of drugs currently taking, presence of comorbidities, and glycemic control.

Operational Definition

Good preventive attitude: If participants scored greater than or equal to the mean score of preventive CKD attitude-related questions (Mondal et al., 2021c).

Poor preventive attitude: If participants scored less than the mean score of preventive CKD attitude-related questions (Mondal et al., 2021c). This outcome variable was measured by computing the raised attitude-related questions and categorized by using a mean value.

Good preventive practice: If participants scored greater than or equal to the mean score of preventive CKD practice-related questions (Mondal et al., 2021c).

Poor preventive practice: If participants scored less than the mean score of preventive CKD practice-related questions (Mondal et al., 2021c). This outcome variable was measured by computing the raised practice-related questions and categorized by using a mean value.

Good glycemic control: When HbA1c level <7 (Hussain et al., 2019).

Poor glycemic control: When HbA1c ≥ 7 (Hussain et al., 2019).

Data Collection Tool, Procedures, and Quality Control

Data were collected by using face-to-face interviewer questionnaires and medical chart review. Questionnaires were adapted from the relevant literatures (Mondal et al., 2021c) (Hussain et al., 2019) (Mondal et al., 2021b). The English version of the questionnaire was translated in to Afan Oromo by language experts for better understanding. It was reviewed and approved by senior experts in the field.

The first part of the questionnaire includes sociodemographic characteristics of the study participants, the second part includes clinical related variables, the third part includes questions related to CKD preventive knowledge, the fourth part includes questions related to CKD preventive attitude and the fifth part includes questions related to the CKD preventive practice.

Data quality was ensured by providing training to data collectors on interview process techniques and ways to collect data. Data were collected by Bachelor of Science (BSc) nurses and supervised by Master of Science (MSc). A pretest of the questionnaire was done on 11 T2DM patients, which were out of the study setting and a reliability of the questionnaire was checked. The Cronbach's alpha value was 0.842 and 0.807 for attitude and practice, respectively.

Statistical Analysis

Data entry was done by Epi data version 4.2.0.0, exported and analyzed by using Statistical Package for the Social Sciences version 23.0. The questionnaires were coded as “0” and “1” while “1” represented the correct answers and “0” represented incorrect answers. The outcome variable was dichotomized and coded as “0” and “1” represented (good attitude = 1 and poor attitude = 0) and practice (good practice = 1 and poor practice = 0). Descriptive statistics such as percent, frequency, and mean were conducted, and the result was presented by using tables, figures, and text. Moreover, bivariable and multivariable logistic regression model were used to check the association between the independent variables and dependent variables. For screening of the variables to move to the multivariable logistic regression analysis, we used p-value of <.25 for the variables in bivariable logistic regression analysis. Hosmer–Lemeshow's goodness-of-fit test was used to check for model fitness and got p-value = 0.714 for CKD preventive attitude, and p-value = .801 for CKD preventive practice. Crude odds ratio and adjusted odds ratio (AOR) with the corresponding 95% CI was calculated and with p values <.05 was considered as statistically significant.

Ethics Approval and Consent to Participate

Ethical clearance was obtained from the Ethical Review and Research Committee of the Nursing Department, College of Health Sciences, Arsi University, Ref. No./AU/H/S/C/CN/272/21. Then, permission was obtained from Asella Referral and Teaching Hospital. The objectives of this study were discussed with all study participants recruited for this study. Besides, the study participants were assured about the confidentiality of the information attained. Lastly, written informed consent was received from the study participants. All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards.

Results

Sociodemographic Characteristics of T2DM Patients

Two hundred sixteen T2DM patients were participated in our study and given a response rate of 100%. More than half 114 (52.8%) of T2DM patients were male. About 90 (41.7%) of them were aged ≥60 years. The majority 160 (74.1%) of them have attended formal education. More than half 191 (88.4%) of them were married. Whereas 158 (73.1%) lived in urban, 92 (42.6%) were working in private business, 87 (40.3%) were orthodox followers, and more than half 150 (69.4%) of them were Oromo by ethnic background (Table 1).

Table 1.

Sociodemographic Characteristics of T2DM Patients Who Were Attending a Diabetic Follow-up Clinic at Asella Referral and Teaching Hospital, 2022 (n = 216).

Variables	Category	Frequency	Percent
Age in years	<40	40	18.5
	40–49	31	14.3
	50–59	55	25.5
	≥60	90	41.7
Gender	Male	114	52.8
Gender	Female	102	47.2
Educational status	No formal education	56	25.9
Educational status	Formal education	160	74.1
Marital status	Single	25	11.6
Marital status	Married	191	88.4
Residence	Urban	158	73.1
Residence	Rural	58	26.9
Occupation	Private business	91	42.6
	Government employee	55	25.5
	Private employee	34	15.7
	Daily laborer	15	6.9
	Unemployed	20	9.3
Religion	Orthodox	87	40.3
	Muslim	80	37.0
	Protestant	47	21.8
	Catholic	2	0.9
Ethnicity	Oromo	150	69.4
	Amara	56	25.9
	Tigre	4	1.9
	Other*	6	2.8
Average monthly income in Ethiopian Birr (ETB)	500–3500	50	25.4
	3500–6000	81	41.1
	6000–8000	49	24.9
	≥8000	17	8.6

Other* indicates Wolaita and Gurage ethnic groups.

Clinical-Related Characteristics of T2DM Patients

Among 216 T2DM patients, the majority 84 (38.9%) of them had a duration of less than 5 years since diagnosed with T2DM. Around 89 (41.2%) of them had a family history of kidney disease, 186 (86.1%) of them have taken ≤2 drugs currently, around 25 (11.6%) of them had comorbidities. Regarding the Hemoglobin A1c level, 6 (66.7%) of them had ≥7 levels (Table 2).

Table 2.

Clinical-Related Factors of T2DM Patients Who Were Attending a Diabetic Follow-up Clinic at Asella Referral and Teaching Hospital, 2022 (n = 216).

Variable	Category	Frequency	Percent
Duration since you diagnosed T2DM in years	<5	84	38.9
	5–10	70	32.4
	10–15	41	19.0
	≥15	21	9.7
Family history of kidney disease	Yes	89	41.2
Family history of kidney disease	No	127	58.8
Number of drugs taking currently	≤2	186	86.1
Number of drugs taking currently	>2	30	13.9
Presence of commodities	Yes	25	11.6
Presence of commodities	No	191	88.4
Number of commodities	1	25	11.6
List of diagnosed commodities	Hypertension	21	9.7
	HIV/AIDS	1	0.5
	Asthma	2	0.9
	Heart failure	1	0.5
Hemoglobin A1c level	<7	3	33.3
Hemoglobin A1c level	≥7	6	66.7

Preventive Attitude of CKD among T2DM Patients

The level of good preventive attitude of CKD among T2DM patients who were attending a diabetic follow-up clinic was 61.6% (n = 133, 95% CI: 55.6–68.0) (Figure 1).

Figure 1.

Level of CKD preventive attitudes among T2DM patients who were attending a diabetic follow-up clinic at Asella Referral and Teaching Hospital, 2022 (n = 216).

Preventive Practice of CKD among T2DM Patients

The level of good preventive practice of CKD among T2DM patients who were attending a diabetic follow-up clinic at Asella referral and teaching hospital was 54.6% (n = 118, 95% CI: 47.7–60.6) (Figure 2).

Figure 2.

Level of CKD preventive practice among T2DM patients who were attending a diabetic follow-up clinic at Asella Referral and Teaching Hospital, 2022 (n = 216).

Factors Associated with Preventive Attitude of CKD among T2DM

To check the association of independent variables with good preventive attitude: age, gender, educational status, marital status, residence, occupation, average monthly income, duration since diagnosed with T2DM, family history of kidney disease, number of drugs currently taking, and presence of comorbidities were checked in a bivariable logistic regression analysis. In bivariable logistic regression analysis, age, marital status, residence, occupation, duration since diagnosed T2DM, and presence of comorbidities were shown a p-value of <.25. But, only age, marital status, residence, and occupation were significantly associated with CKD preventive attitude among T2DM patients in multivariable logistic regression analysis.

The odds of having a good CKD preventive attitude among T2DM patients aged (50–59 years) was 35.1% times (AOR = 0.351, 95% CI: 0.125–0.988, p = .047) more likely when compared with T2DM patients aged ≥60 years old. The likelihood of having a good CKD preventive attitude among T2DM patients who were married was 4.423 times (AOR = 4.423, 95% CI: 1.366–14.314, p = .013) more likely than single T2DM patients. The odds of having a good CKD preventive attitude among T2DM patients’ urban residents was 32.1% times (AOR = 0.321, 95% CI: 0.152–0.680, p = .003) more likely than rural residents. The likelihood of having a good CKD preventive attitude among T2DM patients who were governmental employed was 26.9% times (AOR = 0.269, 95% CI: 0.076–0.954, p = .042) more likely when compared with T2DM patients who were unemployed (Table 3).

Table 3.

Bivariable and Multivariable Logistic Regression Analyses of Factors Associated with Preventive Attitude of CKD among T2DM Patients Who Were Attending a Diabetic Follow-up Clinic at Asella Referral and Teaching Hospital, 2022 (n = 216).

Variables	Categories	Attitude		COR (95% CI)	AOR (95% CI)	p value
Variables	Categories	Good	Poor	COR (95% CI)	AOR (95% CI)	p value
Age in years	<40	26(65.0%)	14(35.0%)	0.929(0.424–.033)	0.923(0.202–4.212)	.917
	40–49	21(67.7%)	10(32.3%)	1.050(0.439–2.509)	0.779(0.204–2.979)	.715
	50–59	26(47.3%)	29(52.7%)	0.448(0.225–0.891)	0.351(0.125–0.988)	.047
	≥60	60(66.7%)	30(33.3%)	Ref.	Ref.
Gender	Male	72(63.2%)	42(36.8%)	1.152(0.665–1.995)	NA
Gender	Female	61(59.8%)	41(40.2%)	Ref.
Educational status	No formal education	37(68.1%)	19(33.9%)	1.298(0.686–2.455)	NA
Educational status	Formal education	96(60.0%)	64(40.0%)	Ref.
Marital status	Single	12(48.0%)	13(52.0%)	Ref.	Ref.
Marital status	Married	121(63.4%)	70(36.6%)	1.873(0.810–4.329)	4.423(1.366–14.314)	.013
Residence	Urban	89(56.3%)	69(43.7%)	0.410(0.208–0.809)	0.321(0.152–0.680)	.003
Residence	Rural	44(75.9%)	14(24.1%)	Ref.	Ref.
Occupation	Private business	56(60.9%)	36(39.1%)	0.519(0.173–1.550)	0.298(0.088–1.008)	.052
	Government employee	28(50.9%)	27(49.1%)	0.346(0.110–1.083)	0.269(0.076–0.954)	.042
	Private employee	24(70.6%)	10(29.4%)	0.800(0.229–2.799)	0.659(0.167–2.607)	.552
	Daily laborer	10(66.7%)	5(33.3%)	0.667(0.152–2.915)	0.505(0.98–2.601)	.414
	Unemployed	15(75.0%)	5(25.0%)	Ref.	Ref.
Monthly income in ETB	500–3500	30(60.0%)	20(40.0%)	Ref.
	3500–6000	49(60.5%)	32(39.5%)	1.021(0.497–2.097)	NA
	6000–8000	29(59.2%)	20(40.8%)	0.967(0.433–2.158)	NA
	≥8000	11(64.7%)	6(35.3%)	1.222(0.398–3.838)	NA
Duration of T2DM	<5	54(64.3%)	30(35.7%)	Ref.	Ref.
	5–10	36(51.4%)	34(48.6%)	0.588(0.308–1.124)	0.429(0.158–1.164)	.097
	10–15	27(65.9%)	14(34.1%)	1.071(0.489–2.348)	0.494(0.121–2.026)	.320
	≥15	16(76.2%)	5(23.8%)	1.778(0.592–5.335)	1.021(0.203–5.124)	.980
Family history of kidney disease	Yes	58(65.2%)	31(34.8%)	Ref.
Family history of kidney disease	No	75(59.1)	52(40.9%)	0.771(0.44–1.352)	NA
Number of drugs currently taking	<2	112(60.2%)	74(39.8%)	Ref.
Number of drugs currently taking	≥2	21(70.0%)	9(30.0%)	1.542(0.669–3.551)	NA
Presence of comorbidity	Yes	19(76.0%)	6(24.0%)	Ref.	Ref.
Presence of comorbidity	No	114(59.7%)	77(40.3%)	0.468(0.179–1.224)	0.353(0.125–1.001)	.052

Notes: Figures in bold show statistically significant (p < 0.05), Ref.; represents the reference category; NA, refers to variables omitted from multivariable logistic regression analysis because of their p-value >0.25 in bivariable logistic regression analysis.

COR = crude odds ratio; AOR = adjusted odds ratio; CI = confidence interval; ETB = Ethiopian Birr; NA = not applicable.

Factors Associated with Preventive Practice of CKD Among T2DM

Similarly, bivariable and multivariable logistic regression analyses were done to check the association of the independent variables with good CKD preventive practice. Primary age, gender, educational status, marital status, residence, occupation, average monthly income, duration since diagnosed with T2DM, family history of kidney disease, number of drugs currently taking, and presence of comorbidities were checked in bivariable logistic regression analysis for their association with good CKD preventive practice. Then, age, gender, educational status, occupation, average monthly income, duration since diagnosed with T2DM, and family history of CKD were shown a p-value of <.25 in bivariable logistic regression analysis. However, only educational status, average monthly income, and duration since diagnosed T2DM were significantly associated with good CKD preventive practice in multivariable logistic regression analysis.

The odds of having good CKD preventive practice among T2DM patients who were attending formal education was 1.686 times (AOR = 1.686, 95% CI: 1.416–5.502, p = .043) more likely when compared with their contrary. The likelihood of having good CKD preventive practice among T2DM patients who had an average monthly income of ≥8000 ETB was 4.048 times (AOR = 4.048, 95% CI: 1.129–14.520, p = .032) more likely when compared with T2DM patients who had an average monthly income of 500–3500 ETB. The odds of having good CKD preventive practice among T2DM patients who had a family history of CKD was 1.417 times (AOR = 1.417, 95% CI: 1.231–7.136, p = .045) more likely when compared with their contrary (Table 4).

Table 4.

Bivariable and Multivariable Logistic Regression Analyses of Factors Associated with Preventive Practice of CKD among T2DM Patients Who Were Attending a Diabetic Follow-up Clinic at Asella Referral and Teaching Hospital, 2022 (n = 216).

Variables	Categories	Practice		COR (95% CI)	AOR (95% CI)	p value
Variables	Categories	Good	Poor	COR (95% CI)	AOR (95% CI)	p value
Age in years	<40	25(62.5%)	15(37.5%)	Ref.	Ref.
	40–49	14(45.2%)	17(54.8%)	0.494(0.190–1.283)	0.692(0.224–2.133)	.521
	50–59	32(58.2%)	23(41.8%)	0.835(0.362–1.924)	1.088(0.328–3.610)	.891
	≥60	47(52.2%)	43(47.8%)	0.656(0.306–1.405)	0.910(0.219–3.791)	.897
Gender	Male	67(58.8%)	47(41.2%)	1.426(0.832–2.442)	1.584(0.855–2.934)	.144
Gender	Female	51(50.0%)	51(50.0%)	Ref.
Educational status	No formal education	25(44.6%)	31(55.4%)	Ref.	Ref.
Educational status	Formal education	93(58.1%)	67(41.9%)	1.721(0.932–3.178)	1.686(1.416–5.502)	.043
Marital status	Single	14(56.0%)	11(44.0%)	1.065(0.460–2.465)	NA
Marital status	Married	104(54.5%)	87(45.5%)	Ref.
Residence	Urban	83(52.5%)	75((47.5%)	Ref.
Residence	Rural	35(60.3%)	23(39.7%)	1.375(0.746–2.525)	NA
Occupation	Private business	43(46.7%)	49(53.3%)	Ref.	Ref.
	Government employee	35(63.6%)	20(36.4%)	1.994(1.005–3.957)	1.830(0.814–4.118)	.144
	Private employee	19(55.9%)	15(44.1%)	1.443(0.654–3.194)	1.297(0.530–3.175)	.569
	Daily laborer	9(60.0%)	6(40.0%)	1.709(0.563–5.193)	2.832(0.757–10.603)	.122
	Unemployed	12(60.0%)	8(40.0%)	1,709(0.639–4.572)	0.559(0.031–10.157)	.694
Average Monthly income in ETB	500–3500	20(40.0%)	30(60.0%)	Ref.	Ref.
	3500–6000	51(63.0%)	30(37.0%)	2.550(1.237–5.257)	3.127(0.360–7.190)	.086
	6000–8000	24(49.0%)	25(51.0%)	1.440(0.650–3.192)	1.579(0.619–4.025)	.339
	≥8000	11(64.7%)	6(35.3%)	2.750(0.876–8.636)	4.048(1.129–14.520)	.032
Duration since diagnosed T2DM	<5 years	50(59.5%)	34(40.5%)	Ref.	Ref.
	5–10 years	34(48.6%)	36(51.4%)	0.642(0.339–1.218)	0.581(0.214–1.583)	.288
	10–15 years	24(58.5%)	17(41.5%)	0.960(0.449–2.050)	0.981(0.244–3.947)	.978
	≥15 years	10(47.6%)	11(52.4%)	0.618(0.237–1.616)	0.763(0.164–3.549)	.730
Family history of kidney disease	Yes	44(49.4%)	45(50.6%)	1.428(0.828–2.463)	1.417(1.231–7.136)	.045
Family history of kidney disease	No	74(58.3%)	53(41.7%)	Ref.	Ref.
Number of drugs currently taking	≤2	104(55.9%)	82(44.1%)	1.449(0.669–3.141)	NA
Number of drugs currently taking	>2	14(46.7%)	16(53.3%)	Ref.
Presence of comorbidities	Yes	14(56.0%)	11(44.0%)	1.065(0.460–2.455)	NA
Presence of comorbidities	No	104(54.5%)	87(45.5%)	Ref.

Notes: Table in bold show statistically significant (p < 0.05).

Discussion

In this study, the level of good CKD preventive attitude among T2DM patients who were attending a diabetic clinic at Asella Referral and Teaching Hospital was 61.6% (n = 133, 95% CI: 55.6–68.0). This study finding was higher than the study conducted in Bangladesh, 28.6% (Mondal et al., 2021b). This might be due to the study period differences; the study was conducted in 2019. There is also a study population difference. In the study conducted in Bangladesh, it included only T2DM patients who had a follow-up for ≥1 year and excluded T2DM patients aged >70 years.

This study finding was lower than the study conducted in Fiji Islands, 68.9% (Zibran & Mohammadnezhad, 2019). This might be because of study population differences; the study conducted in Fiji has included T2DM patients diagnosed with CKD. But in this study, we have excluded T2DM patients who had already confirmed for CKD. There is also a sociodemographic difference; they have included only participants aged ≥30 years.

The odds of having a good preventive attitude among T2DM patients aged (50–59 years) was 35.15 times (AOR = 0.351, 95% CI: 0.125–0.988, p = .047) more likely when compared with T2DM patients aged ≥60 years old. This study finding was supported by a study done in Fiji Island (Zibran & Mohammadnezhad, 2019). The likelihood of having a good preventive attitude among T2DM patients who were married was 4.423 times (AOR = 4.423, 95% CI: 1.366–14.314, p = .013) more likely than single T2DM patients. This finding was supported by a study done in Fiji Island (Zibran & Mohammadnezhad, 2019).

Furthermore, the odds of having a good preventive attitude among T2DM patients’ urban residents was 32.1% times (AOR = 0.321, 95% CI: 0.152–0.680, p = .003) more likely than rural residents. The likelihood of having a good preventive attitude among T2DM patients who were governmental employed was 26.9% times (AOR = 0.269, 95% CI: 0.076–0.954, p = .042) more likely when compared with T2DM patients who were unemployed. This study was supported by a study conducted in Bangladesh (Mondal et al., 2021a).

The level of CKD good preventive practice among T2DM patients who were attending a diabetic clinic at Asella Referral and Teaching Hospital was 54.6% (n = 118, 95% CI: 47.7–60.6). This study finding was lower when compared with a study done in Bangladesh, 82.1% (Mondal et al., 2021b). This might be due to sociodemographic and study population differences. This study finding was also lower than the study conducted in Fiji Islands, 88.3% (Zibran & Mohammadnezhad, 2019). This could be due to that study population differences, and they have included patients confirmed for CKD. There is also sociodemographic difference.

The odds of having good preventive practice among T2DM patients who were attending formal education was 1.686 times (AOR = 1.686, 95% CI: 1.416–5.502, p = .043) more likely when compared with their contrary. This study was supported by a study done in Palestine (Badran et al., 2023). The likelihood of having good preventive practice among T2DM patients who had an average monthly income of ≥8000 ETB was 4.048 times (AOR = 4.048, 95% CI: 1.129–14.520, p = .032) more likely when compared with T2DM patients who had an average monthly income of 500–3500 ETB. The odds of having good preventive practice among T2DM patients who had a family history of CKD was 1.417 times (AOR = 1.417, 95% CI: 1.231–7.136, p = .045) more likely when compared with their contrary.

Strengths and Limitations

Since there was no study done at the study setting, this could give essential insights for the concerned bodies. The study design used for this study was a cross-sectional study. This study design does not help to determine the cause and effect. Furthermore, there were limitations of the literatures on this essential topic globally. This study would lessen the challenges for future researchers who will be concerned to do a study on this topic. Moreover, since this study was done at a single hospital, the findings of this study may not be generalizable to the national level.

Implications for Practice

This study gives important evidence to support T2DM patients to minimize the occurrence of CKD among them. These findings would also deliver vital information for healthcare providers, policy makers and implementers, government, and researchers to provide a special attention for T2DM patients in order to prevent the development of CKD. Health education programs need to occur to improve the preventive attitude and practice toward CKD among T2DM patients.

Conclusion

The level of good preventive attitude and practice toward CKD among T2DM patients who were attending a diabetic clinic at Asella Referral and Teaching Hospital was 61.6% (n = 133, 95% CI: 55.6–68.0) and 54.6% (n = 118, 95% CI: 47.7–60.6), respectively. The multivariable logistic regression analysis indicated that age, marital status, residence, and occupation were significantly associated with good preventive attitude of T2DM patients. Whereas educational status, average monthly income, and duration since diagnosed with T2DM were significantly associated with good CKD preventive practice.

Footnotes

Declaration of Conflicting Interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

ORCID iD

Addisu Dabi Wake

References

Badran

Bahar

Tammam

Bahar

Khalil

Koni

A. A.

Zyoud

S. H.

(2023). The relationship between diabetes-related knowledge and kidney disease knowledge, attitudes, and practices: A cross-sectional study. BMC Public Health, 23(1), 480. https://doi.org/10.1186/s12889-023-15390-8

Bikbov

Purcell

C. A.

Levey

A. S.

Smith

Abdoli

Abebe

Adebayo

O. M.

Afarideh

Agarwal

S. K.

Agudelo-Botero

Ahmadian

Al-Aly

Alipour

Almasi-Hashiani

Al-Raddadi

R. M.

Alvis-Guzman

Amini

Andrei

C. L.

Vos

(2020). Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the global burden of disease study 2017. The Lancet, 395(10225), 709–733. https://doi.org/10.1016/S0140-6736(20)30045-3

Calvo-Hueros

J. I.

Martín-Hidalgo-Barquero

M. V.

Morales-Gabardino

J. A.

Buitrago

(2021). Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain). An observational study. Primary Care Diabetes, 15(2), 391–396. https://doi.org/10.1016/j.pcd.2020.11.015

CDC. (2022). Kidney disease surveillance system. https://nccd.cdc.gov/ckd/

Deng

Wang

Yang

Zheng

Deng

Xiang

Zhu

Zhai

Zhang

Dai

Gao

(2021). Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease from 1990 to 2019. Frontiers in Endocrinology, 12, 809. https://doi.org/10.3389/fendo.2021.672350

Ephraim

Mantey

Atombo

Sakyi

Fondjo

Tashie

Agbodzakey

Botchway

Amankwaa

(2018). Chronic kidney disease in type 2 diabetes mellitus patients: Comparison of KDIGO and KDOQI guidelines. Alexandria Journal of Medicine, 54, https://doi.org/10.1016/j.ajme.2018.07.003

Geletu

A. H.

Teferra

A. S.

Sisay

M. M.

Teshome

D. F.

(2018). Incidence and predictors of chronic kidney diseases among type 2 diabetes mellitus patients at St. Paul’s Hospital, Addis Ababa, Ethiopia. BMC Research Notes, 11(1), 532. https://doi.org/10.1186/s13104-018-3618-9

Hussain

Habib

Najmi

(2019). Limited knowledge of chronic kidney disease among type 2 diabetes Mellitus patients in India. International Journal of Environmental Research and Public Health, 16, 1443. https://doi.org/10.3390/ijerph16081443

Jitraknatee

Ruengorn

Nochaiwong

(2020). Prevalence and risk factors of chronic kidney disease among type 2 diabetes patients: A cross-sectional study in primary care practice. Scientific Reports, 10(1), 6205. https://doi.org/10.1038/s41598-020-63443-4

10.

Kidney Education (2023). Causes of chronic kidney disease. https://kidneyeducation.com/English/Causes-of-Chronic-Kidney-Disease/10

11.

Kidney Resource Center (2023). Symptoms & stages of CKD | kidney resource center | Washington University in St. Louis. Washington University School of Medicine in St. Louis. https://kidney.wustl.edu/kidney-diseases/symptoms-stages-of-ckd/

12.

Levin

Stevens

P. E.

(2011). Early detection of CKD: The benefits, limitations and effects on prognosis. Nature Reviews Nephrology, 7(8), 446–457. https://doi.org/10.1038/nrneph.2011.86

13.

Luyckx

V. A.

Al-Aly

Bello

A. K.

Bellorin-Font

Carlini

R. G.

Fabian

Garcia-Garcia

Iyengar

Sekkarie

van Biesen

Ulasi

Yeates

Stanifer

(2021). Sustainable development goals relevant to kidney health: An update on progress. Nature Reviews Nephrology, 17(1), 15–32. https://doi.org/10.1038/s41581-020-00363-6

14.

Mondal

Ritu

R. B.

Rahman

M. S.

Sarker

R. C.

Banik

P. C.

(2021a). Knowledge attitude and practices towards chronic kidney disease among type-2 diabetic patients in Bangladesh. International Journal of Education and Health, 5(1), Article 1. https://doi.org/10.17267/2594-7907ijhe.v5i1.3004

15.

Mondal

Ritu

R. B.

Rahman

M. S.

Sarker

R. C.

Banik

P. C.

(2021b). Knowledge attitude and practices towards chronic kidney disease among type-2 diabetic patients in Bangladesh. International Journal of Health Education, 5(1), Article 1. https://doi.org/10.17267/2594-7907ijhe.v5i1.3004

16.

Mondal

Ritu

R. B.

Rahman

Sarker

R. C.

Banik

P. C.

(2021c). Knowledge attitude and practices towards chronic kidney disease among type-2 diabetic patients in Bangladesh. International Journal of Health Education, 5(1). https://doi.org/10.17267/2594-7907ijhe.v5i1.3004

17.

Mondal

Ritu

Rahman

Sarker

Banik

(2021d). Knowledge attitude and practices towards chronic kidney disease among type-2 diabetic patients in Bangladesh. International Journal of Health Education, 5, https://doi.org/10.17267/2594-7907ijhe.v5i1.3004

18.

Naser

A. Y.

Alwafi

Alotaibi

Salawati

Samannodi

Alsairafi

Alanazi

A. F. R.

Dairi

M. S.

(2021). Prevalence of chronic kidney diseases in patients with diabetes Mellitus in the Middle East: A systematic review and meta-analysis. International Journal of Endocrinology, 2021, 4572743. https://doi.org/10.1155/2021/4572743

19.

NIH (2020, March 4). The link between diabetes and kidney disease—Blog—NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/professionals/diabetes-discoveries-practice/the-link-between-diabetes-and-kidney-disease

20.

NHS (2023, March 22). Chronic kidney disease—symptoms. NHS. https://www.nhs.uk/conditions/kidney-disease/symptoms/

21.

Rahim

Mitra

Haque

Samdani

Zaman

Uddin

(2017). Prevalence of chronic kidney disease stages 3-5 among patients with type 2 diabetes mellitus in Bangladesh. IMC Journal of Medical Sciences, 11, https://doi.org/10.3329/imcjms.v11i1.31934

22.

Rajput

Kumar

K. M. P.

Seshadri

Agarwal

Talwalkar

Kotak

Raza

Vasnawala

Kumar

(2017). Prevalence of chronic kidney disease (CKD) in Type 2 diabetes mellitus patients: START-India study. Journal of Diabetes & Metabolism, 08(02). https://doi.org/10.4172/2155-6156.1000722

23.

Shiferaw

W. S.

Akalu

T. Y.

Aynalem

Y. A.

(2020). Chronic kidney disease among diabetes patients in Ethiopia: A systematic review and meta-analysis. International Journal of Nephrology, 2020, e8890331. https://doi.org/10.1155/2020/8890331

24.

Stages of Kidney Disease (2023). Stages of kidney disease: Symptoms and treatments. New Health Advisor. https://www.newhealthadvisor.org/Stages-of-Kidney-Disease.html

25.

Stages of Kidney Disease: Symptoms and Treatments (2020, April 5). New Health Advisor. http://www.newhealthadvisor.org/Stages-of-Kidney-Disease.html

26.

Tannor

E. K.

Sarfo

F. S.

Mobula

L. M.

Sarfo-Kantanka

Adu-Gyamfi

Plange-Rhule

(2019). Prevalence and predictors of chronic kidney disease among Ghanaian patients with hypertension and diabetes mellitus: A multicenter cross-sectional study. The Journal of Clinical Hypertension, 21(10), 1542–1550. https://doi.org/10.1111/jch.13672

27.

Thomas

M. C.

Cooper

M. E.

Zimmet

(2016). Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nature Reviews Nephrology, 12(2), Article 2. https://doi.org/10.1038/nrneph.2015.173

28.

Veeraish

(2021). Causes and risk factors of chronic kidney disease. Verywell Health. https://www.verywellhealth.com/common-causes-of-chronic-kidney-disease-2085786

29.

von Elm

Altman

D. G.

Egger

Pocock

S. J.

Gøtzsche

P. C.

Vandenbroucke

J. P.

Initiative

S. T. R. O. B. E.

(2007). The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Annals of Internal Medicine, 147(8), 573–577. https://doi.org/10.7326/0003-4819-147-8-200710160-00010

30.

Wikipedia. (2023). Chronic kidney disease. In Wikipedia. https://en.wikipedia.org/w/index.php?title=Chronic_kidney_disease&oldid=1187399217

31.

Wikipedia. (2024). Asella. In Wikipedia. https://en.wikipedia.org/w/index.php?title=Asella&oldid=1203452480

32.

Zibran

M. A.

Mohammadnezhad

(2019). Determinants of knowledge, attitude and practice in patients with both type 2 diabetes and chronic kidney disease in Fiji. F1000Research, 8, 239. https://doi.org/10.12688/f1000research.18188.1

Chronic Kidney Disease Preventive Attitude,Practice,and Associated Factors among Type 2 DM Patients in Ethiopia: A Cross-Sectional Study

Abstract

Introduction

Objective

Methods

Result

Conclusion

Keywords

Introduction

Review of Literature

Methods

Study Area

Study Period

Study Design

Research Questions

Population

Source Population

Study Population

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Sample Size Determination

Sampling Techniques and Procedures

Study Variable

Dependent Variable

Independent Variable

Operational Definition

Data Collection Tool, Procedures, and Quality Control

Statistical Analysis

Ethics Approval and Consent to Participate

Results

Sociodemographic Characteristics of T2DM Patients

Clinical-Related Characteristics of T2DM Patients

Preventive Attitude of CKD among T2DM Patients

Preventive Practice of CKD among T2DM Patients

Factors Associated with Preventive Attitude of CKD among T2DM

Factors Associated with Preventive Practice of CKD Among T2DM

Discussion

Strengths and Limitations

Implications for Practice

Conclusion

Footnotes

Declaration of Conflicting Interests

Funding

ORCID iD

References